149 related articles for article (PubMed ID: 28180127)
21. Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.
Acevedo D; Salvador MP; Girbes J; Estan N
J Clin Med Res; 2018 May; 10(5):396-404. PubMed ID: 29581802
[TBL] [Abstract][Full Text] [Related]
22. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
23. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
[TBL] [Abstract][Full Text] [Related]
24. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
Jensen MD; Kjeldsen J; Nathan T
Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899
[TBL] [Abstract][Full Text] [Related]
25. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
[TBL] [Abstract][Full Text] [Related]
26. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
Boschetti G; Garnero P; Moussata D; Cuerq C; Préaudat C; Duclaux-Loras R; Mialon A; Drai J; Flourié B; Nancey S
Inflamm Bowel Dis; 2015 Feb; 21(2):331-6. PubMed ID: 25625487
[TBL] [Abstract][Full Text] [Related]
27. Prediction of treatment outcome and relapse in inflammatory bowel disease.
Kato J; Yoshida T; Hiraoka S
Expert Rev Clin Immunol; 2019 Jun; 15(6):667-677. PubMed ID: 30873890
[TBL] [Abstract][Full Text] [Related]
28. Verification of the Bühlmann fCAL turbo faecal calprotectin assay on the Binding Site Optilite benchtop analyser.
Handley SA; Dote NP; Wanandy T; Prentice L
Pract Lab Med; 2023 Aug; 36():e00318. PubMed ID: 37649548
[TBL] [Abstract][Full Text] [Related]
29. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease.
Quail MA; Russell RK; Van Limbergen JE; Rogers P; Drummond HE; Wilson DC; Gillett PM
Inflamm Bowel Dis; 2009 May; 15(5):756-9. PubMed ID: 19107785
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
[No Abstract] [Full Text] [Related]
31. Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease.
Sollelis E; Quinard RM; Bouguen G; Goutte M; Goutorbe F; Bouvier D; Pereira B; Bommelaer G; Buisson A
World J Gastroenterol; 2019 May; 25(19):2354-2364. PubMed ID: 31148906
[TBL] [Abstract][Full Text] [Related]
32. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of faecal calprotectin in a symptom-based algorithm for early diagnosis of inflammatory bowel disease adjusting for differential verification bias using a Bayesian approach.
Viola A; Fontana A; Belvedere A; Scoglio R; Costantino G; Sitibondo A; Muscianisi M; Inferrera S; Bruno LM; Alibrandi A; Trifirò G; Fries W
Scand J Gastroenterol; 2020 Oct; 55(10):1176-1184. PubMed ID: 32838582
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease.
Jang HW; Kim HS; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Intest Res; 2016 Oct; 14(4):305-313. PubMed ID: 27799881
[TBL] [Abstract][Full Text] [Related]
35. Early change in faecal calprotectin predicts primary non-response to anti-TNFα therapy in Crohn's disease.
Pavlidis P; Gulati S; Dubois P; Chung-Faye G; Sherwood R; Bjarnason I; Hayee B
Scand J Gastroenterol; 2016 Dec; 51(12):1447-1452. PubMed ID: 27400728
[TBL] [Abstract][Full Text] [Related]
36. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
37. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
[TBL] [Abstract][Full Text] [Related]
39. Correlation of rapid point-of-care
Rodriguez A; Yokomizo L; Christofferson M; Barnes D; Khavari N; Park KT
World J Gastrointest Pharmacol Ther; 2017 May; 8(2):127-130. PubMed ID: 28533922
[TBL] [Abstract][Full Text] [Related]
40. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
